Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, ROCKWELL MEDICAL, INC. reported revenue of $69M, down 31.8% year over year. Operating margin was -6.8% and net margin -7.7%, on a free-cash-flow margin of -1.7% with capital expenditure at 0.8% of revenue. Every figure is computed directly from RMTI's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $69M | -6.8% | -7.7% |
| FY2024 | $101M | 0.6% | -0.5% |
| FY2023 | $84M | -8.0% | -10.1% |
| FY2022 | $73M | -23.0% | -25.7% |
| FY2021 | $62M | -49.0% | -52.8% |
How does RMTI compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.